Article

Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome?

Current Opinion in Cardiology
DOI: 10.1097/HCO.0000000000000070
1Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Current guidelines suggest 12 months of DAPT after an initial presentation with ACS. Emerging evidence suggest that in selected populations shorter duration might be acceptable. © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Author supplied keywords

Cite

CITATION STYLE

APA

Christodoulidis, G., Baber, U., & Mehrana, R. (2014). Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? Current Opinion in Cardiology. Lippincott Williams and Wilkins. https://doi.org/10.1097/HCO.0000000000000070

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free